MedPath

A clinical trial to study the effects of mifepristone and misoprostol given at same time for abortion.

Phase 3
Completed
Conditions
Health Condition 1: null- Medical abortion in less than 10 weeks of pregnancy
Registration Number
CTRI/2010/091/001422
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Prescence of intrauterine pregnancy

Gestational age not exceeding 63 days at administration of Mifepristone

Aged >16 yrs

Willingness to comply with schedule of follow up visits

Exclusion Criteria

Ectopic Pregnancy
Systemic corticosteroid therapy
Adrenal sufficiency
Asthma
Glaucoma
Poorly controlled seizures
Hb <10 gm%
Coagulopathy
Anticoagulant therapy
Pregnancy with intrauterine device in situ

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success of Medical abortionTimepoint: 14 days
Secondary Outcome Measures
NameTimeMethod
Compare the efficacy of concurrent protocol with 48 hours protocolTimepoint: 14 days
© Copyright 2025. All Rights Reserved by MedPath